36 Pages

18561

Course: PHARM 300, Fall 2011
School: Rutgers
Rating:
 
 
 
 
 

Word Count: 1496

Document Preview

PATIENTS TOTAL - 175 120 100 80 No of patients 60 40 20 0 Series1 YES 67 NO 108 FAMILY HISTORY 160 HYPERTENSION & DIABETES 140 120 No of patients 100 80 60 40 20 0 Series1 Railway hospital 149 Private 26 Regular treatment Irregular treatm 127 48 TREATMENT 100 90 80 70 60 50 40 Classification of patient 91 33 30 20 10 1 0 2 33 15 CLASS-1 CLASS-2 CLASS-3 CLASS-4 category...

Register Now

Unformatted Document Excerpt

Coursehero >> New Jersey >> Rutgers >> PHARM 300

Course Hero has millions of student submitted documents similar to the one
below including study guides, practice problems, reference materials, practice exams, textbook help and tutor support.

Course Hero has millions of student submitted documents similar to the one below including study guides, practice problems, reference materials, practice exams, textbook help and tutor support.
PATIENTS TOTAL - 175 120 100 80 No of patients 60 40 20 0 Series1 YES 67 NO 108 FAMILY HISTORY 160 HYPERTENSION & DIABETES 140 120 No of patients 100 80 60 40 20 0 Series1 Railway hospital 149 Private 26 Regular treatment Irregular treatm 127 48 TREATMENT 100 90 80 70 60 50 40 Classification of patient 91 33 30 20 10 1 0 2 33 15 CLASS-1 CLASS-2 CLASS-3 CLASS-4 category RTD.EMPLOYEE DEPENTANTS 20 18 16 14 12 10 8 6 4 2 0 1 AMPUTATION RETINOPATHY 1 1 7 19 COMPLICATION 6 3 NEPHROPATHY HEART ATTACK STOKE NON-HEALING ULCER BODY MASS INDEX 115 120 100 80 49 60 40 20 5 6 0 < 17 Series1 5 > 17-< 27 115 > 27- < 32 49 > 32 6 WAIST-HIP RATIO: How to Calculate Waist-Hip Ratio Waist Hip Ratio is calculated by dividing your waist measurement by your hip measurement. Using a tape measure, measure your waist below your rib-cage but above your belly button. Then measure your hips - the widest part of your butt. Finally, divide your waist measurement by your hip measurement. Ideally, women should have a waist-to-hip ratio of 0.8 or less. Ideally, men should have a waist-to-hip ratio of 0.95 or less SMOKING YES 26% NO 74% YES NO DIET PATTERN 5% 95% Vegetarian Non- Vegetarian EYE CHECK UP 45% 55% YES NO ALCOHOL YES 42% NO 58% YES NO LIPID PROFILE DONE 13% NOT DONE 87% DONE NOT DONE FIBER DIET 29% 71% Y ES NO REGULAR CHECK UP AT RH/PER NO 33% YES 67% YES NO EXERCISE 29% 71% Y ES NO REGULAR TREATMENT 27% 73% YES NO SOURCE OF INFORMATION 5% 3% 4% 88% RADIO/TV NEWSPAPER MEDICAL STAFF FRIENDS 160 KNOWLEDGE YES-136 140 120 YES-102 100 YES-96 NO-101 NO-91 YES-84 YES-74 NO-93 YES-82 80 NO-79 NO-73 60 NO-39 40 20 WHAT IS SYMPTOMS COMPLICAWHAT IS DM? SYMPTOMS COMPLICAHT? OF DM TION OF DM OF HT TION OF HT 0 140 ATTITUDE NO-121 120 NO-107 100 NO-99 80 YES-76 YES-68 60 YES-54 40 20 0 HOW TO CONTROL DM? HOW TO MONITOR DM? HOE TO CONTROL HT? PRACTICE 160 NO-141 140 NO-125 120 NO-105 100 YES-84 80 YES-70 YES-62 60 YES-50 NO-91 NO-113 40 YES-35 20 0 HEALTHY/ REGUL WEIGHT BLOOD, URINE BALANCED REGULAR REGULAR BP CHECK UP EXECISE CHECK UP SUGAR CHECK UP DIET DISCUSSION: This study was conducted to gauge the effects of knowledge on the attitude-followed by practice among diabetic and HT patients, attending Railway health unit, Tondiarpet Marshaling Yard. Total patients for K.A.P study were 175. 68 of them were suffering from HT, followed by 66 with DM alone and 41 patients with DM and HT. 114 male patients and 61 female patients were included in this study. Most of the patients age ranged from 51-60 years (78), followed by 41- 50 years (73), > 60 years (16), and 30 40 years (8). The most common source of information on diabetes was from medical staffs (80 T0 85%). This could be due to the fact that all newly diagnosed diabetic and HT patients are thoroughly briefed on diabetes by the doctors and the medical assistants. The respondents were tested on 6 aspects of knowledge on diabetes - what they understand by the disease, symptoms, complications, prevention, diet and exercise. 50% to 60% of the total 175 patients are having the adequate knowledge about HT and DM. 30% to 40% of the patients are having the attitude to control DM and HT. 80% to 85% of the patients collected the source of information about DM and HT from the Medical Department. Random blood sugar of 60% to 65% of diabetic patients was above 200 mgms. Only 3 Diabetic patients were periodically monitored by Hba1c level in blood from private laboratory. 95% of the total patients are Non-Vegetarian. 58% of the male patients are alcoholic, and 26% Male patients are smokers. 49/175 patients are over weight and 6/175 patients are Obese. Only 85% of the patients were not done lipid profile and 45% of the patients were monitored by eye check-up. 48% of the patients preferred private lab for their routine investigation for follow-up as their residence far away. Conclusion: In many cases, we can prevent or treat these diseases, but in order to do so, we need to persuade people to make changes in diet, physical activity, and their own awareness and monitoring of the disease's progression changes that are psychologically difficult and that present formidable barriers for individuals and health systems alike. While genetic predisposition may play a role in type II diabetes, its onset and severity can be modified by diet and activity. Complications can be reduced by addressing these risk factors and achieving blood pressure control and avoiding tobacco use. To improve health in the next century, we will have to do a better job of applying the knowledge we already have and ensuring access to effective and economically affordable diabetes and HT care to the population that is essential for preventing, reducing diabetes and HT related complications. Certain measures are recommended to improve people's perception and practice towards Diabetes and HT. A better-structured education programme is recommended to every individual especially those with diabetes and HT. The programme should cover topics such as symptoms, complications, preventive diet measures, and exercise. This should be done at all levels including through school, working centres and to the railway colony people. A tailored programme with gradual introduction of exercise is encouraged with consideration of the individual's age. A weight reduction programme incorporating diet modification is also recommended for those who are over weight, where as a weight maintenance programme is encouraged for those with normal body weight. A continuous self-monitoring system should be introduced for diabetic patients. This enables them to continuously monitor their blood glucose level as well as control their diet accordingly. studies on similar context but with wider scope and much larger sample size is recommended to confirm findings of this study and to further explore other relevant factors especially factors influencing practice and perception. SUGGESTION AND RECOMMENDATION GOALS OF DIETARY THERAPY: 1) Restoration of optimal blood glucose and S.lipid levels. 2) Provision of adequate calories to maintain normal weight and Improvement of overall health in diabetes. Three strategies in preventing coronary heart diseases in DM and HT Patients 1. Substituting unsaturated fats (poly unsaturated fats) for saturated fats and trans fats. 2. Increasing use of Omega-3 fatty acids from fish oil. 3. Diet rich in fruits, vegetables, nuts, and whole grains but low in refined grains. CALORIES PRESCRIPTION: Calorie prescription is an important element in nutritional management. Calorie needs vary with age, sex and activity level. Recommended calorie level is based on individual's desired weight. IDEAL BODY WEIGHT (IBW) KG =(HT IN CM - 100) X 0.9 CALORIE INTAKE BASED ON ACTIVITY IS AS FOLLOWS: SEDENTARY 20 - 25 CAL/KG (IBW) MODERATE 26 - 30 CAL/KG (IBW) STRENUOUR 31 - 35 CAL/KG (IBW) An energy deficit of 500 k.cal/day will help to reduce 500 gms of weight every week. Dietary therapy for people with diabetes should be individualized with consideration given to usual eating habits and other lifestyle factors. Nutrition recommendations are implemented to attain the goals. Micronutrients such as vitamins and minerals are supplemented as required, sodium restriction in those with hypertension and cardiac failure. Diet with low glycaemic index is preferred to high glycaemic index. Complex carbohydrates are ideal as they are slowly digested and absorbed with lesser steep in raise of Post Prandial glucose and insulin response. HEALTHY DIET/ BALANCED DIET Protein - 15 % of total energy Carbohydrates - 50 to 60 % of total energy Total fats - 25 to 35 % of total energy Saturated fat - < 7 % total energy Poly unsaturated fat - up to 10 % total energy Mono unsaturated fat - up to 20 % total energy Fiber diet - 20 to 30 grams per day Vitamins and minerals Water Salt - 2400 milligrams per day (One teaspoon of salt) Cholesterol - < 300 mgm/day EXERCISE Brisk walking, healthy diet will be helpful for longevity for people with Type2diabetes, and plays an important role in the prevention of over weight and obesity. TV watching is significantly associated with the risk of obesity and type 2 diabetes. Obesity can indirectly do some changes in the body which include the following: Raising the levels of LDL (Bad cholesterol) Lowering the levels of HDL (Good Cholesterol) Raising the levels of Triglycerides Increasing the Blood Pressure Increasing the risk of Type 2 Diabetes Exercise is known to Increase insulin sensitivity, Improve glucose tolerance, Promote weight loss, Reduce triglyceride levels Increasing the levels of HDL cholesterol Decreasing the levels of LDL cholesterol Reduces the risk of hardening of arteries (atheroscelerosis) Improving blood flow, which reduces the risk of infection in the lower legs and foot. People with diabetes are encouraged to exercise for at least 30 minutes, at least three or four times per week. Exercise precautions : Starting slowly and building up to longer/ harder workouts. Keeping track of one's heart rate. Warming up slowly before exercise and cooling down slowly afterwards. To calculate the maximum target heart rate (220 One's age), and maintain the 70% to 80% one's maximum heart rate during exercise. After exercise, the goal is to decrease the heart rate and relax the muscles by doing slow stretches. To consult physician before beginning any exercise program. To wear appropriate shoes and socks. To have an exercise partner, snacks, and medical I.D card. Testing glucose levels both before and after exercise. YOGA FOR DIABETES Types of yoga recommended for diabetes: Pranayama Dhanurasana Ardha-Matsendrasana Pachi motanasana Halasana And Vajarasana Dhanurasana is most effective. These are practiced on an empty stomach for 30 minutes followed by shavasana for 10 15 mts. Effect of yoga Fall in FBS level Fall in PPBS level Reduction in systolic B.P Reduction in Diastolic B.P Reduction in dosage requirement of anti hypertensives Increase in HDL cholesterol Decrease in LDL cholesterol Decrease in free fatty acids Decrease in VLDL cholesterol Reduction in fasting insulin levels Increase in insulin receptors And Insulin sensitivity increases.
Find millions of documents on Course Hero - Study Guides, Lecture Notes, Reference Materials, Practice Exams and more. Course Hero has millions of course specific materials providing students with the best way to expand their education.

Below is a small sample set of documents:

Rutgers - PHARM - 300
UPDATE ON CHILDHOOD DIABETES MELLITUSAbdelaziz Elamin MD, PhD, FRCPCH Professor of Child Health Sultan Qaboos UniversityDEFINITION The term diabetes mellitus describes a metabolic disorder of multiple etiologies characterized by chronic hyperglycemia
Rutgers - PHARM - 300
New Feature of NCEP ATP III:* Identification of the Metabolic SyndromePositive diagnosis based on the presence of three or more of the following:Risk FactorMen WomenDefining Level&gt;102 cm (&gt;40 in) &gt;88 cm (&gt;35 in) 150 mg/dL &lt;40 mg/dL &lt;50 mg/dL 130/ 85
Rutgers - PHARM - 300
NAT I ONAL PROGRAMA DI ABETES NACIONAL N E D UC AT O I EDUCACION EN DIABETES P R OGR AMCambiando la forma en que es tratada la diabetesPropsito de la sesin Actualizar las actividades de PNED Revisar los logros de grupos de trabajo raciales/tnicos Plane
Rutgers - PHARM - 300
2 Wilfred Y. Fujimoto Dxyer: 10 2 1980 0.67% 1996 3.21% 15 5 1600 2025 3700 Nikkei (DEFEND) NIDDM(GENNID) 15 2 2 (GENNID) Nikkei (DEFEND) 0% 50% urban W.Samoa W.Samoa Diabetes Care 16:157;1993 1970 2 2 16%~20% 4%~5% 2 2 2 2 2 2
Rutgers - PHARM - 300
2 Peter H. Bennett lpapple(DXY) 1998 2010 30-64 2 2 * * 2 2 1 47 89 73 55 6 59 Pima Pima 2 2 2 1978 1991 2 2 Pima 2 Pima 25-44 Pima 2 5 2 37-46 Pima 64 IGT 2 2 2 110 660 25-74 577 IGT 530 6 IGT 2
Rutgers - PHARM - 300
2 Peter H. Bennett DXY 2 A B 2 2 + 95 2 2 95 CI 2 6 &lt;2.0 mg/kgMBS.min 2.0 - 5.0 mg/ kgMBS.min &gt;5.0 mg/kgMBS.min 2 A B A B &quot; &quot; &quot; &quot; ( ) 1 22 2 2
Rutgers - PHARM - 300
Gwen256-DXY - - -- - - (SES) ( ) 051015 / 100, 000202530 ? - - - - DPP
Rutgers - PHARM - 300
Simon Weitzman, MD,MPH 1 GCT OGTT WHO NDDG Coustan (mg/dL) WHO 7 140 5g NDDG (100g) 105 195 180 1 2 200 165 155 145 140 3 Coustan 95 (100g) 50g &gt;=186mgdL 38.2% 93.3% 78.6% 70.0%50g &gt;=186mgdL 38.2% 93.3% 19.5% 97.2% VS 57.4% 27.7% 4
Rutgers - PHARM - 300
Patrick J O'Connor &quot; 3 182,000 10-15 70% ASA 2 57% - 60 - 8 3 - 3 - 5 3 $60, 000 $50, 000 $40, 000 $30, 000 $20, 000 $10, 000 $0 6% 7% 8% HBAl c 9% &gt;10%$8, 600 $9, 000 $9, 600$38, 700$40, 200$42, 500$45, 600$49, 700$10, 400 $11, 600 -
Rutgers - PHARM - 300
2000.12Gillian HawthorneHawthorne 1990 David Hadden Belfast Lois Jovanovic St Vincent 48/1000 8.9/1000 83/1000 21.3/1000 1000 Merseyside 1990 94 36.1 377.6 N/A9.7% 5% 1987 1996 11.8/1000 6.7/1000 28 7 16 1994 7 1 1997 6 30 24 &gt;24
Rutgers - PHARM - 300
NIKOLA STOJANOVS KI EDEG EASD - 10 2.2 200/100000 1995 1.35 2025 20.25 88 90 2 2 2 20% &gt;27kg/m2 &gt;45 IFG IGT &gt;140/90 mmHg &lt;35mg/ml(0.90mmol/l) / &lt;250 mg/ml(2.82mmol/l) 4.5kg 2 75 80 2 WHR &quot;
Rutgers - PHARM - 300
John S Yudkin - Y2K 2000 10 6 - - ? + + + - PAI-1 6+C- + 6 24 6 6 PWHR HPA AXIS 6 CRP
Rutgers - PHARM - 300
Craig.Hanis,Ph.D. Hoaston 2001 23 &amp; - - - - / - / - ? Starr 2 2 2 2 NIDDM1 NIDDM1 31kb 10 10 SNP 43,19,63 OGTT Sreenen et al,(2000).Diabetes 49 suppl 1:A62 10 10 FSIVGTT SNP 43,19.63 15
Rutgers - PHARM - 300
2 HNF-1a NIDDM1 10 - 15 3?2 MODY Chr.11 NDDM1Chr.7 Chr.11chr.9 chr.10Chr.15chr.3chr.21 - MODY Starr County Texas Eastern Finns GENNID FUSION San Antonio Utah Pima Indians Canadian Oji-Cree Old Order Amish ,3 , , , , , , , 49 27 , ADA/ Gh
Rutgers - PHARM - 300
Ake Lernmark Joerg Ermann &amp; C.Garrison Fathman Nature Immunology 2,759-761(2001) C 0-15 15-34 20% 60% 10% 55% &lt;5% 46% 90% 20 HLA DQ2,DQ8, DQ2/8 DQ6.2 35 INS VNTR 2.5% 5' CTLA-4 AT 2-3% 20-30% 10-15% ECHO ABO CBV4 T V- T1DM = (Varela-Calvino
Rutgers - PHARM - 300
Bruce W. Case, F.R.C.P.(C) MCGILL : : Bruce.Case@mcgill.ac http:/www.thename.org/causedeath/main.htm 1998 http:/cma.ca/cmaj/vol-158/issue-10/1317.htm 1960 1 2 17-18 3 19 a. Rokitansky( b. Virchow( c. Osler- d. 1 20 60 50% 2 10% 3 a.36.5% 1923
Rutgers - PHARM - 300
2 Abdullatif Husseini 2 2 2 2 2 2 2 11.1mmol/l ITG 2 7.8&lt; 11.1mmol/l Last M 1995 Dictionary of epidemiology 2 &quot; 2 1997 2000 6.2 5480 3.5 9960 2025 7.6 7220 4.9 22770 2 2 1 2 1 2 IGT,IFT,GDM. 2 Beaglhole &quot; the
Rutgers - PHARM - 300
MSc I Ross LawrensonPostgraduate Medical School University of SurreyI ICA IAA , GADA 90 I 10 35 Atkinson MA Eisenbarth GS. Lancet 2001 358 221 9 1000 I I 0 4 5 9 10 14 15 19 100 000 1992 I 48 I 30 I 8.2 /100,000/ 21.5 /100,000/ I I Molba
Rutgers - PHARM - 300
/ Pe t e r M l gr o m DDS i 2 003 2 DXYer lesenhower / b e t a - b e t a - b e t a - b e t a - Be ve r l y A. Da l e - Cr unk, PhD Ri c ha r d J ur e vi c , DDS Nor ma W l l s , RDH, M e PH M r j or i e Ts ut s ui , De nt a l St ud a Na n
Rutgers - PHARM - 300
&quot; &quot; DXYer lesenhower 68 14 1926335N 38 c a uf i e l d Pe di a t r i c De nt i s t r y 1997. 19. 491- 8) &quot; &quot; Eva Sode r l i ng a nd p a ul i i s oka nga s Yl i vi e s ka Tu r ku 195 60 2 169 &quot; &quot; 6 147 4 2 . 2 6% 2 ) CHX) CHX 40 2 2 7. 5
Rutgers - PHARM - 300
- 50 Paul Zimmet,AO , , , ( ) , Resonance wang(dxy) , , , , .MAIMONIDES- &quot; &quot; &quot; &quot; West 1964 6 1964 20 1979 7 1980 8 (IDF) 1980 . . . Charles Dianne , John Jarrett- , . Ron LaPorte 20 80 . 1 . 200 . 1 . , (11) (12) 2 . Bedford(Hary keen),Whiteha
Rutgers - PHARM - 300
lpapple(DXY) 1999 1986-1999 1986 1986 IFL 1986 1,225,000 210,538 1,362,339 3,675,000 6,934,000 16 123,000 160,000 1 123,000 10 1.30
Rutgers - PHARM - 300
Metabolic Syndrome, Diabetes, and Cardiovascular Disease: Implications for Preventive CardiologyNathan D. Wong, PhD, FACC, FAHA Professor and Director Heart Disease Prevention Program Division of Cardiology University of California, IrvineOverview of Di
Rutgers - PHARM - 300
Evidence Supporting Aggressive Glycemic ControlTreatment of Type 2 DiabetesSites of Action of Therapeutic Options for Type 2 DiabetesDCCT: Effects of Intensive vs Conventional Glycemic ControlUKPDS: DesignUKPDS: Effects of Intensive (Sulfonylurea/Ins
Rutgers - PHARM - 300
Basic Considerations for Prevention of Blindness in Diabetes Care and EducationProf. Morsi Arab Emeritus Professor of Medicine University of AlexandriaPrevelance of DM in whole Egypt in Different Age Groups16 14 12 % population 10 8 6 4 2 0 0.62 0.80 3
Rutgers - PHARM - 300
Diabetes and Metabolic DiseasePaul R. EarlFacultad de Ciencias Biolgicas Universidad Autnoma de Nuevo Len San Nicols, NL 66450, Mexico pearl@dsi.uanl.mxNicolas PaulescuDiscoveryIn the middle of the 19th century, evidence from autopsies started to sug
Rutgers - PHARM - 300
DIABETES IN SUB-SAHARAN AFRICADr Kaushik RamaiyaThe future burden of diabetes in sub-Saharan Africa20 18 16 14 12 10 8 6 4 2 02030millions2025 2010Amos et al, 1997 WHO, King et al, 1998 WHO, Wild et al, 2003Africa is experiencing a rapid epidemiol
Rutgers - PHARM - 300
Modifiable Risk Factors for Type 2 Diabetes 2009 Middle Eastern Region Epidemiology Supercourse Alexandria, EgyptEdward Gregg, PhD Epidemiology and Statistics Branch Division of Diabetes Translation Centers for Disease Control and Prevention Atlanta, GA
Rutgers - PHARM - 300
Epidemiology of Type 2 Diabetes 2009 Middle Eastern Region Epidemiology Supercourse Bibliotheca Alexandria, EgyptEdward Gregg, PhD Epidemiology and Statistics Branch Division of Diabetes Translation Centers for Disease Control and Prevention Atlanta, GA
Rutgers - PHARM - 300
Dr. Tawfik A. M. KhojaMBBS, DPHC, FRCGP, FFPH,FRCP (UK) Director General - GCCRiyadh 11/1/1430H - 8/1/2009Dr. Tawfik A. Khoja 1 &quot; (22 ) &quot;&quot; Is then one who Walks headlong, with his face Grovelling, better guided, Or one who walks Evenly on a Straight
Rutgers - PHARM - 300
Diabetes and Other Non-Communicable Diseases / EM Regional PerspectiveDr. Ibtihal Fadhil RA/ NCD/ Health promotion and Protection/ EMRO/WHOFirst BA Regional Workshop on the Epidemiology of Diabetes and Other Non-Communicable Diseases , Bibliotheca Alexa
Rutgers - PHARM - 300
Diabetes as a Global Health Problem The IDF meets the ChallengeBy Prof. Morsi Arab IDF Chairman MENA RegionMENAReported Incidence of Type1 Diabetes at the MENA Region per 100.000 population under 15 yrs ( Diabetes Atlas 2006) Afghanistan Algeria Bahra
Rutgers - PHARM - 300
Dr. Mona Hassan Ahmed Hassan Prof. BiostatisticsWhat to do before sitting to PC?Statistical Software How to generate and interpret results?Data CodingTransformation of qualitative information into Numbers OR SymbolsData PreparationEither the infor
Rutgers - PHARM - 300
Genetics of DiabetesJan Dorman, PhD University of Pittsburgh School of Nursing jsd@pitt.eduType 1 Diabetes (T1D)Type 1 DiabetesCaused by the destruction of the pancreatic beta cells Insulin is no longer produced Leads to hyperglycemia, ketoacidosis a
Rutgers - PHARM - 300
Integrating Genomics into Clinical PracticeJan Dorman, PhD University of Pittsburgh School of Nursing jsd@pitt.edu Applications of Genomics to Clinical PracticeMolecular diagnosis $1000 for human genome sequencePrediction of a healthy person's risk o
Rutgers - PHARM - 300
A Public Health Approach Towards Prevention of IDDMRonald E. LaPorte, University of PittsburghType I diabetes IncidencePRC MEX JPN Cuba PLD DEN UK US NOR SCO SWD CAN FIN 0 5 10 15 20 25 30 35 40Green mountains range beyond the northern wall White wate
Rutgers - PHARM - 300
WHO Collaborating CenterJanice Dorman, Ph.D. Director Molecular Epidemiology Ronald LaPorte, Ph.D. Director Disease Monitoring and TelecommunicationsGSPHThe Importance of IDDM RegistriesDiabetes Epidemiology Team in PittsburghY Allan Drash, M.D. Y Do
Rutgers - PHARM - 300
Cambridge 1983Cambridge Diabetes Epidemiology Course July, 1999 Thinking out of the boxNetwork Everyone in Prevention2009: A HEALTH ODYSSEYGlobal Life Expectancy20 years30 years40 years 70 yearsWHO DIAMOND Project100 Centers 50 CountriesIf Car
Rutgers - PHARM - 300
GLOBAL STRATEGIES FOR THE PREVENTION OF DIABETES AND OTHER NONCOMMUNICABLE DISEASESAla Alwan Assistant Director-General World Health OrganizationWorkshop on Epidemiology of Diabetes and Other Noncommunicable Diseases (Bibliotheca Alexandrina, 8 January
Rutgers - PHARM - 300
Epidemiology of 1 Diabetes Mellitus (T1DM) among children of Novosibirsk City, RussiaSazonova O.V., Simonova G.I., Shubnikov E.V., Galenok V.A., Vaskina E.A., Nikiforov O.A., Akopova A.G., Choubnikova J.M., Nikitin Yu.P. Novosibirsk State Medical Univers
Rutgers - PHARM - 300
TYPES OF STUDIES IN DIABETES EPIDEMIOLOGY :TYPES OF STUDIES BASED ON: : Purpose Time Cost FeasibilityTYPES OF STUDY Observational ) ) Descriptive Analytical Cross-sectional - Retrospective - Prospective - Experimental A STUDY DESIGN FOR THE OUTCOMES
Rutgers - PHARM - 300
(2009 8 ) / : 1948 193 %80 %60 : : , , , , , , , , , : -1 , - 2 -3 . : 1. 2. 3. 4. 5. 6. 7. : , ,
Rutgers - PHARM - 300
(II) 2009 - : : : Normal IGTType 2 DMComplications Disability Death : : &quot; &quot; - () : . 30 . . . . . Kahn et al., Nature, 2006 : 40 30%20 10 0l In di a ba nI nd ia Ur ba nF iji l n 52 00 al d l ra ba on i ze ra 19 20 Ru Ru po g
Rutgers - PHARM - 300
Sntomas emocionales y prctica sexual de pacientes con diabetes mellitus tipo 2 y controles sanos M.C.M. Mara de Lourdes Garca Campos Facultad de Enfermera y Obstetricia de Celaya Universidad de Guanajuato Y Dra. Mara Raquel Huerta Franco Universidad de G
Rutgers - PHARM - 300
PhD Public Health, Suez Canal University, Egypt Diabetes MSc, Cardiff University, United Kingdom Dr. Rasha SalamaDiabetes mellitus (DM) is a group of diseases characterized by high levels of blood glucose resulting from defects in insulin production, in
Rutgers - PHARM - 300
Diabetes Self ManagementLaura WintersteenArleth, MN, RN,CDELearning Objectiveso Understand the impact of diabetes o Distinguish the different types of Diabetes o Identify treatment options for diabetes management o Identify methods of applying the Chro
Rutgers - PHARM - 300
Diabetic KetoacidosisAbdelaziz Elamin Professor of Pediatric Endocrinology University of Khartoum, SudanIntroductionDKA is a serious acute complications of Diabetes Mellitus. It carries significant risk of death and/or morbidity especially with delayed
Drexel - MUSIC - MUS130
Introduction to MusicMUSC 130 2:00-2:50 Nesbitt 111Instructor: Mr. Bruce Kaminsky. Office: MacAlister 2012.Phone (215) 895-2451 email: bk46@drexel.eduDescription: Course objectives: learn principal musical genres influencing western music from antiqu
Shanghai Normal University - ACC - 410
1 2 3
Shanghai Normal University - ACC - 410
1 2 3 4 5 1 1 A B
Shanghai Normal University - ACC - 410
1 2 3 4 5 6 7 8 123478956 10 11 12 13 14 15 161 60 000 10 200 60 00060 10 20070 20070
Shanghai Normal University - ACC - 410
1 2 ( ) 1 P2382 ( ) 1 2 ( ) ( ) 1
Shanghai Normal University - ACC - 410
( ) ( ) 1 2 13 24
Shanghai Normal University - ACC - 410
1 2 (1) (2) 1 1 12 31 365 (3) 30 90 (4)2000 1 1 1 2
Shanghai Normal University - ACC - 410
11 22 312005 1 1 A 100 000 17% 10 20 20 000 A ( 97 000 20 000117 000117 00011797 00097 20 000
Shanghai Normal University - ACC - 410
1 2 = + + + + + + + - 3 1 = + - 2 = + 3 = + 4 = + 5 = + +
Shanghai Normal University - ACC - 410
( ) ( ) ( ) ( ) 1 2 3 4 5 1 2 3 4 5
Purdue University - Main Campus - ECON - 252
1.GDP is defined asa) the market value of all goods and services produced within a country in a given period of time.b) the market value of all goods and services produced by the citizens of a country, regardless ofwhere they are living, in a given pe
Purdue University - Main Campus - ECON - 252
1.The rate of inflation in the United States is 3 percent per year and the rate of inflation in Europe is 6percent per year. If purchasing power parity holds true the Euro price of the U.S. dollar will:a) increase 9 percent each year.c) fall 3 percent
Purdue University - Main Campus - ECON - 252
FIGURE1:TheCircularFlowDiagramHouseholds:Households Own the factors of production, Own the factors of production,sell/rent them to firms for incomesell/rent them to firms for income Buy and consume goods &amp; services Buy and consume goods &amp; services
Purdue University - Main Campus - ECON - 252
1.In an open economy:a) S = I + NCOb) S + T G = NXc) Y = C + I + Gd) None of the above are correct.2.Consider a country with a population of 2.7 million people. Its adult population is 1.6 million. Thelabor force participation rate is 72% and the